{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:52:03Z","timestamp":1772085123522,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["754550"],"award-info":[{"award-number":["754550"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundacion La Caixa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbi.2021.08.233","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:08:55Z","timestamp":1630462135000},"page":"330-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Real-world experience of assessing antibodies against the N-methyl-D-aspartate receptor (NMDAR-IgG) in psychiatric patients. A retrospective single-centre study"],"prefix":"10.1016","volume":"98","author":[{"given":"Helena","family":"Ari\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2021.08.233_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.08.233_b0010","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2021.08.233_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.654602","article-title":"Neural autoantibodies in cerebrospinal fluid and serum in clinical high risk for psychosis, first-episode psychosis, and healthy volunteers","volume":"12","author":"Bien","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2215-0366(20)30432-6","article-title":"Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies","volume":"8","author":"Cullen","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.08.233_b0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2021.08.233_b0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2021.08.233_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00967-3","article-title":"Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis","volume":"10","author":"Endres","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.08.233_b0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/appi.neuropsych.17120343","article-title":"The psychiatric phenotype of anti-NMDA receptor encephalitis","volume":"31","author":"Gibson","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci. appi.neuropsych."},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1980","article-title":"Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors\u2019 cooperation","volume":"11","author":"Gin\u00e9 Serv\u00e9n","year":"2021","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.bbi.2021.08.233_b0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2021.08.233_b0065","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0070","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1212\/NXI.0000000000000659","article-title":"Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis","volume":"7","author":"Guasp","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.bbi.2021.08.233_b0075","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.08.233_b0080","doi-asserted-by":"crossref","first-page":"e0230436","DOI":"10.1371\/journal.pone.0230436","article-title":"Neuropsychological and psychiatric outcomes in encephalitis: A multi-centre case-control study","volume":"15","author":"Harris","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2021.08.233_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.08.233_b0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamapsychiatry.2019.3679","article-title":"Absence of autoantibodies against neuronal surface antigens in sera of patients with psychotic disorders","volume":"77","author":"Hoffmann","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2021.08.233_b0095","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-017-01700-3","article-title":"Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients","volume":"8","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2021.08.233_b0100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbi.2021.08.233_b0105","doi-asserted-by":"crossref","unstructured":"Lennox, B.R., Palmer-Cooper, E.C., Pollak, T., Hainsworth, J., Marks, J., Jacobson, L., Lang, B., Fox, H., Ferry, B., Scoriels, L., Crowley, H., Jones, P.B., Harrison, P.J., Vincent, A., PPiP study team, 2017. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. The lancet. Psychiatry 4, 42\u201348. doi: 10.1016\/S2215-0366(16)30375-3.","DOI":"10.1016\/S2215-0366(16)30375-3"},{"issue":"10","key":"10.1016\/j.bbi.2021.08.233_b0110","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/appi.ajp.2012.12050646","article-title":"Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia","volume":"169","author":"Masdeu","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2021.08.233_b0115","doi-asserted-by":"crossref","unstructured":"Pollak, T., Vincent, A., Iyegbe, C., Coutinho, E., Jacobson, L., Rujescu, D., Stone, J., Jezequel, J., Rogemond, V., Jamain, S., Groc, L., David, A., Egerton, A., Kahn, R.S., Honnorat, J., Dazzan, P., Leboyer, M., McGuire, P., 2020. Relationship between serum NMDA receptor antibodies and response to antipsychotic treatment in first episode psychosis. Biol. Psychiatry. doi: 10.1016\/j.biopsych.2020.11.014.","DOI":"10.1016\/j.biopsych.2020.11.014"},{"key":"10.1016\/j.bbi.2021.08.233_b0120","doi-asserted-by":"crossref","unstructured":"Pollak, T.A., Kempton, M.J., Iyegbe, C., Vincent, A., Irani, S.R., Coutinho, E., Menassa, D.A., Jacobson, L., de Haan, L., Ruhrmann, S., Sachs, G., Riecher-R\u00f6ssler, A., Krebs, M.O., Amminger, P., Glenth\u00f8j, B., Barrantes-Vidal, N., van Os, J., Rutten, B.P.F., Bressan, R.A., van der Gaag, M., Yolken, R., Hotopf, M., Valmaggia, L., Stone, J., David, A.S., Calem, M., Tognin, S., Modinos, G., de Haan, L., van der Gaag, M., Velthorst, E., Kraan, T.C., van Dam, D.S., Burger, N., Nelson, B., McGorry, P., Pantelis, C., Politis, A., Goodall, J., Borgwardt, S., Ittig, S., Studerus, E., Smieskova, R., Gadelha, A., Brietzke, E., Asevedo, G., Asevedo, E., Zugman, A., Rosa, A., Racioppi, A., Monsonet, M., Hinojosa-Marqu\u00e9s, L., Kwapil, T.R., Kazes, M., Daban, C., Bourgin, J., Gay, O., Mam-Lam-Fook, C., Nordholm, D., Randers, L., Krakauer, K., Glenth\u00f8j, L., Nordentoft, M., Gebhard, D., Arnhold, J., Klosterk\u00f6tter, J., Lasser, I., Winklbaur, B., Delespaul, P.A., van Os, J., McGuire, P., 2020. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Mol. Psychiatry. doi: 10.1038\/s41380-020-00899-w.","DOI":"10.1038\/s41380-020-00899-w"},{"issue":"1","key":"10.1016\/j.bbi.2021.08.233_b0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2021.08.233_b0130","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s00415-020-10329-0","article-title":"Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates","volume":"268","author":"Thouin","year":"2021","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2021.08.233_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1-3","key":"10.1016\/j.bbi.2021.08.233_b0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2014.11.001","article-title":"Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: a description of a treated case series","volume":"160","author":"Zandi","year":"2014","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.bbi.2021.08.233_b0145","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/jnnp-2014-308736","article-title":"Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes","volume":"86","author":"Zandi","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121005237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121005237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:16:18Z","timestamp":1760170578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121005237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":29,"alternative-id":["S0889159121005237"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.08.233","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world experience of assessing antibodies against the N-methyl-D-aspartate receptor (NMDAR-IgG) in psychiatric patients. A retrospective single-centre study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.08.233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}